List of Cubist Pharmaceuticals patents

Patents where

Current Assignee

Name

Cubist Pharmaceuticals

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7527807 Compositions and methods for increasing the oral absorption of antimicrobials	Patent 7527807 was granted and assigned to Cubist Pharmaceuticals on May, 2009 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	7527807	May 5, 2009
‌ US Patent 8003673 Daptomycin for the treatment of biofilm and catheter salvage	Patent 8003673 was granted and assigned to Cubist Pharmaceuticals on August, 2011 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	8003673	August 23, 2011
‌ US Patent 7408025 Lipopeptides as antibacterial agents	Patent 7408025 was granted and assigned to Cubist Pharmaceuticals on August, 2008 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	7408025	August 5, 2008
‌ US Patent 8969570 Beta-lactamase inhibitors	Patent 8969570 was granted and assigned to Cubist Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8969570	March 3, 2015
‌ US Patent 8940897 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors	Patent 8940897 was granted and assigned to Cubist Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8940897	January 27, 2015
‌ US Patent 8476425 Tazobactam arginine compositions	Patent 8476425 was granted and assigned to Cubist Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8476425	July 2, 2013
‌ US Patent 8685957 Tazobactam arginine compositions	Patent 8685957 was granted and assigned to Cubist Pharmaceuticals on April, 2014 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	8685957	April 1, 2014
‌ US Patent 8058238 High purity lipopeptides	Patent 8058238 was granted and assigned to Cubist Pharmaceuticals on November, 2011 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	8058238	November 15, 2011
‌ US Patent 8835382 Lipopeptide compositions and related methods	Patent 8835382 was granted and assigned to Cubist Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	8835382	September 16, 2014
‌ US Patent 8129342 High purity lipopeptides	Patent 8129342 was granted and assigned to Cubist Pharmaceuticals on March, 2012 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	8129342	March 6, 2012
‌ US Patent 9006421 Cephalosporin compositions and methods of manufacture	Patent 9006421 was granted and assigned to Cubist Pharmaceuticals on April, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	9006421	April 14, 2015
‌ US Patent 8853357 High purity lipopeptides	Patent 8853357 was granted and assigned to Cubist Pharmaceuticals on October, 2014 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8853357	October 7, 2014
‌ US Patent 8916709 1,2,4-oxadiazole and 1,2,4-thiadiazole β-lactamase inhibitors	Patent 8916709 was granted and assigned to Cubist Pharmaceuticals on December, 2014 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8916709	December 23, 2014
‌ US Patent 8927724 Isoxazole beta-lactamase inhibitors	Patent 8927724 was granted and assigned to Cubist Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8927724	January 6, 2015
‌ US Patent 8962844 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors	Patent 8962844 was granted and assigned to Cubist Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8962844	February 24, 2015
‌ US Patent 9193729 Inhibiting transient receptor potential ion channel TRPA1	Patent 9193729 was granted and assigned to Cubist Pharmaceuticals on November, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	9193729	November 24, 2015
‌ US Patent 9120796 B-lactamase inhibitor picoline salt	Patent 9120796 was granted and assigned to Cubist Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	9120796	September 1, 2015
‌ US Patent 8962843 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors	Patent 8962843 was granted and assigned to Cubist Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8962843	February 24, 2015
‌ US Patent 9108966 Beta-lactamase inhibitors	Patent 9108966 was granted and assigned to Cubist Pharmaceuticals on August, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	9108966	August 18, 2015
‌ US Patent 9120795 Crystalline form of a β-lactamase inhibitor	Patent 9120795 was granted and assigned to Cubist Pharmaceuticals on September, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	9120795	September 1, 2015
‌ US Patent 8933232 1,3,4-oxadiazole and 1,3,4-thiadiazole beta-lactamase inhibitors	Patent 8933232 was granted and assigned to Cubist Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8933232	January 13, 2015
‌ US Patent 8933233 1,3,4-oxadiazole and 1,3,4-thiadiazole β-lactamase inhibitors	Patent 8933233 was granted and assigned to Cubist Pharmaceuticals on January, 2015 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8933233	January 13, 2015
‌ US Patent 8796224 Methods for preparing purified lipopeptides	Patent 8796224 was granted and assigned to Cubist Pharmaceuticals on August, 2014 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8796224	August 5, 2014
‌ US Patent 8846610 Methods for preparing purified lipopeptides	Patent 8846610 was granted and assigned to Cubist Pharmaceuticals on September, 2014 by the United States Patent and Trademark Office.	Cubist Pharmaceuticals	Cubist Pharmaceuticals	United States Patent and Trademark Office	8846610	September 30, 2014
‌ US Patent 8968781 Therapeutic compositions	Patent 8968781 was granted and assigned to Cubist Pharmaceuticals on March, 2015 by the United States Patent and Trademark Office.		Cubist Pharmaceuticals	United States Patent and Trademark Office	8968781	March 3, 2015

Results per page:

31 results

0 selected

31 results

0 selected